Cannabinoids in disguise: Δ9-Tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles

Neuropharmacology

Volumn 75, Issue , 2013, Pages 145-154

  Wiley, Jenny L ^a   Marusich, Julie A ^a   Lefever, Timothy W ^a   Grabenauer, Megan ^a   Moore, Katherine N ^a   Thomas, Brian F ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

Abuse liability; Delta 9 tetrahydrocannabinol; Drug discrimination; Synthetic cannabinoids; UR 144; XLR 11

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; GLUCURONIDE; INDOLE DERIVATIVE; RIMONABANT; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG; UR 144; XLR 11; [(1 (5 FLUOROPENTYL) 1H INDOL 3 YL) (2,2,3,3 TETRAMETHYLCYCLOPROPYL)METHANONE]; [(1 PENTYL 1H INDOL 3 YL) (2,2,3,3 TETRAMETHYLCYCLOPROPYL)METHANONE];

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CARBOXYLATION; CATALEPSY; CONTROLLED STUDY; DEFLUORINATION; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; HYDROXYLATION; HYPOTHERMIA; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MALE; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; URINALYSIS; URINARY EXCRETION;

ABUSE LIABILITY; DELTA-9-TETRAHYDROCANNABINOL; DRUG DISCRIMINATION; SYNTHETIC CANNABINOIDS; UR-144; XLR-11;

ANIMALS; CANNABINOID RECEPTOR AGONISTS; CANNABINOIDS; CYCLOHEXANOLS; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRONABINOL; DRUG ADMINISTRATION SCHEDULE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; INDOLES; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PROTEIN BINDING; RECEPTOR, CANNABINOID, CB1; SULFUR ISOTOPES; TRANSFECTION; TRITIUM;

EID: 84883017678     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.07.022     Document Type: Article

References (59)

1. American Association of Poison Control Centers Synthetic Marijuana 2013 http://www.aapcc.org/alerts/synthetic-marijuana/ (accessed 29.03.13.)
2. B.K. Atwood, J. Huffman, A. Straiker, and K. Mackie JWH018, a common constituent of 'spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonist Br. J. Pharmacol. 160 2010 585 593
3. B.K. Atwood, D. Lee, A. Straiker, T.S. Widlanski, and K. Mackie CP47,497-C8 and JWH073, commonly found in 'spice' herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists Eur. J. Pharmacol. 659 2011 139 145
4. M.M. Aung, G. Griffin, J.W. Huffman, M. Wu, C. Keel, B. Yang, V.M. Showalter, M.E. Abood, and B.R. Martin Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding Drug Alcohol Depend. 60 2000 133 140 (Pubitemid 30625016)
5. 9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication Neurosci. Biobehav. Rev. 16 1992 55 62
6. R.L. Barrett, J.L. Wiley, R.L. Balster, and B.R. Martin Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats Psychopharmacology (Berl.) 118 1995 419 424
7. R.H. Bateman, R. Carruthers, J.B. Hoyes, C. Jones, J.I. Langridge, A. Millar, and J.P.C. Vissers A novel precursor ion discovery method on a hybrid quadrupole orthogonal acceleration time-of-flight (Q-TOF) mass spectrometer for studying protein phosphorylation J. Am. Soc. Mass Spectrom. 13 2002 792 803 (Pubitemid 36871613)
8. G.K. Bhanushali, G. Jain, H. Fatima, L.J. Leisch, and D. Thornley-Brown AKI associated with synthetic cannabinoids: a case series Clin. J. Am. Soc. Nephrol. 8 2013 523 526
9. C.S. Breivogel, and S.R. Childers Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition J. Pharmacol. Exp. Ther. 295 2000 328 336
10. Center for Disease Control and Prevention Acute kidney injury associated with synthetic cannabinoid use - multiple states, 2012 MMWR Morb. Mortal Wkly Rep. 62 2013 93 98
11. D.R. Compton, M.R. Johnson, L.S. Melvin, and B.R. Martin Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents J. Pharmacol. Exp. Ther. 260 1992 201 209
12. D.R. Compton, L.H. Gold, S.J. Ward, R.L. Balster, and B.R. Martin Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol J. Pharmacol. Exp. Ther. 263 1992 1118 1126 (Pubitemid 23157189)
13. D.R. Compton, K.C. Rice, B.R. De Costa, R.K. Razdan, L.S. Melvin, M.R. Johnson, and B.R. Martin Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities J. Pharmacol. Exp. Ther. 265 1993 218 226 (Pubitemid 23320964)
14. A.O. Cox, R.C. Daw, M.D. Mason, M. Grabenauer, P.G. Pande, K.H. Davis, J.L. Wiley, P.R. Stout, B.F. Thomas, and J.W. Huffman Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoids J. Anal. Toxicol. 36 2012 293 302
15. R. Denooz, J.C. Vanheugen, M. Frederich, P. de Tullio, and C. Charlier Identification and structural elucidation of four cannabimimetic compounds (RCS-4, AM-2201, JWH-203 and JWH-210) in seized products J. Anal. Toxicol. 37 2013 56 63
16. Drug Enforcement Administration, Department of Justice Schedules of controlled substances: temporary placement of three synthetic cannabinoids into schedule I. Final order Fed. Regist. 78 95 2013 28735 28739
17. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) EMCDDA 2009 Thematic Paper - Understanding the 'Spice' Phenomenon 2009 Office for Official Publications of the European Communities Luxembourg Available from: http://www.emcdda.europa.eu/attachements.cfm/att-80086-EN- Spice%20Thematic%20paper%20-%20final%20version.pdf
18. M.B. Forrester, K. Kleinschmidt, E. Schwarz, and A. Young Synthetic cannabinoid and marijuana exposures reported to poison centers Hum. Exp. Toxicol. 31 2012 1006 1011
19. J.M. Frost, M.J. Dart, K.R. Tietje, T.R. Garrison, G.K. Grayson, A.V. Daza, O.F. El-Kouhen, B.B. Yao, G.C. Hsieh, M. Pai, C.Z. Zhu, P. Chandran, and M.D. Meyer Indol-3-ylcycloalkyl ketones: effects of N1 substituted indole side chain variations on CB(2) cannabinoid receptor activity J. Med. Chem. 53 2010 295 315
20. 2 cannabinoid receptor activity J. Med. Chem. 51 2008 1904 1912 (Pubitemid 351438872)
21. B.C. Ginsburg, D.R. Schulze, L. Hruba, and L.R. McMahon JWH-018 and JWH-073: delta-tetrahydrocannabinol-like discriminative stimulus effects in monkeys J. Pharmacol. Exp. Ther. 340 2012 37 45
22. M. Grabenauer, W.L. Krol, J.L. Wiley, and B.F. Thomas Analysis of synthetic cannabinoids using high-resolution mass spectrometry and mass defect filtering: implications for nontargeted screening of designer drugs Anal. Chem. 84 2012 5574 5581
23. G. Griffin, E.J. Wray, W.K. Rorrer, P.J. Crocker, W.J. Ryan, B. Saha, R.K. Razdan, B.R. Martin, and M.E. Abood An investigation into the structural determinants of cannabinoid receptor ligand efficacy Br. J. Pharmacol. 126 1999 1575 1584 (Pubitemid 29182341)
24. E.W. Gunderson, H.M. Haughey, N. Ait-Daoud, A.S. Joshi, and C.L. Hart "Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans Am. J. Addict. 21 2012 320 326
25. L. Hruba, B. Ginsburg, and L.R. McMahon Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by delta-9-tetrahydrocannabinol treatment in rhesus monkeys J. Pharmacol. Exp. Ther. 342 2012 843 849
26. J.W. Huffman, and L.W. Padgett Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes Curr. Med. Chem. 12 2005 1395 1411 (Pubitemid 40872583)
27. J.W. Huffman, D. Dai, B.R. Martin, and D.R. Compton Design, synthesis and pharmacology of cannabimimetic indoles Bioorg. Med. Chem. Lett. 4 1994 563 566 (Pubitemid 24131892)
28. J.W. Huffman, P.V. Szklennik, A. Almond, K. Bushell, D.E. Selley, H. He, M.P. Cassidy, J.L. Wiley, and B.R. Martin 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles Bioorg. Med. Chem. Lett. 15 2005 4110 4113 (Pubitemid 41132671)
29. J.W. Huffman, G. Zengin, M.J. Wu, J. Lu, G. Hynd, K. Bushell, A.L. Thompson, S. Bushell, C. Tartal, D.P. Hurst, P.H. Reggio, D.E. Selley, M.P. Cassidy, J.L. Wiley, and B.R. Martin Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists Bioorg. Med. Chem. 13 2005 89 112 (Pubitemid 39575695)
30. M. Hutter, S. Broecker, S. Kneisel, and V. Auwarter Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques J. Mass Spectrom. 47 2012 54 65
31. T.U. Järbe, H. Deng, S.K. Vadivel, and A. Makriyannis Cannabinergic aminoalkylindoles, including AM678 = JWH018 found in 'spice', examined using drug (Delta9-tetrahydrocannabinol) discrimination for rats Behav. Pharmacol. 22 2011 498 507
32. P. Kavanagh, A. Grigoryev, A. Melnik, and A. Simonov The identification of the urinary metabolites of 3-(4-methoxybenzoyl)-1-pentylindole (RCS-4), a novel cannabimimetic, by gas chromatography-mass spectrometry J. Anal. Toxicol. 36 2012 303 311
33. P. Kavanagh, A. Grigoryev, S. Savchuk, I. Mikhura, and A. Formanovsky UR-144 in products sold via the internet: identification of related compounds and characterization of pyrolysis products Drug Test Anal. 2013 1456 10.1002/dta (Epub ahead of print)
34. 9- tetrahydrocannabinol Psychopharmacology (Berl.) 203 2009 241 250
35. P.J. Little, D.R. Compton, M.R. Johnson, L.S. Melvin, and B.R. Martin Pharmacology and stereoselectivity of structurally novel cannabinoids in mice J. Pharmacol. Exp. Ther. 247 1988 1046 1051 (Pubitemid 19022114)
36. B.K. Logan, L.E. Reinhold, A. Xu, and F.X. Diamond Identification of synthetic cannabinoids in herbal incense blends in the United States J. Forensic Sci. 57 2012 1168 1180
37. C. Manera, T. Tuccinardi, and A. Martinelli Indoles and related compounds as cannabinoid ligands Mini Rev. Med. Chem. 8 2008 370 387 (Pubitemid 351606778)
38. B.R. Martin, D.R. Compton, B.F. Thomas, W.R. Prescott, P.J. Little, R.K. Razdan, M.R. Johnson, L.S. Melvin, R. Mechoulam, and S.J. Ward Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs Pharmacol. Biochem. Behav. 40 1991 471 478
39. L.R. McMahon, B.C. Ginsburg, and R.J. Lamb Cannabinoid agonists differentially substitute for the discriminative stimulus effects of delta(9)-tetrahydrocannabinol in C57BL/6J mice Psychopharmacology (Berl.) 198 2008 487 495 (Pubitemid 351754667)
40. R. Mechoulam, J.J. Feigenbaum, N. Lander, M. Segal, T.U.C. Järbe, A.J. Hiltunen, and P. Consroe Enantiomeric cannabinoids: stereospecificity of psychotropic activity Experientia 44 1988 762 764
41. K.G. Shanks, T. Dahn, G. Behonick, and A. Terrell Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry J. Anal. Toxicol. 36 2012 360 371
42. V.M. Showalter, D.R. Compton, B.R. Martin, and M.E. Abood Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands J. Pharmacol. Exp. Ther. 278 1996 989 999 (Pubitemid 27166944)
43. T. Sobolevsky, I. Prasolov, and G. Rodchenkov Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids Drug Test Anal. 2012 1418 10.1002/dta (Epub ahead of print)
44. B.F. Thomas, A.F. Gilliam, D.F. Burch, M.J. Roche, and H.H. Seltzman Comparative receptor binding analyses of cannabinoid agonists and antagonists J. Pharmacol. Exp. Ther. 285 1998 285 292 (Pubitemid 28207598)
45. N. Uchiyama, M. Kawamura, R. Kikura-Hanajiri, and Y. Goda URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products Forensic Sci. Int. 227 2013 21 32
46. R.E. Vann, J.A. Warner, K. Bushell, J.W. Huffman, B.R. Martin, and J.L. Wiley Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice Eur. J. Pharmacol. 615 2009 102 107
47. D.L. Wells, and C.A. Ott The "new" marijuana Ann. Pharmacother. 45 2011 414 417
48. J.M. Wiebelhaus, J.L. Poklis, A. Poklis, R.E. Vann, A.H. Lichtman, and L.E. Wise Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice Drug Alcohol Depend. 126 2012 316 323
49. J.L. Wiley, and B.R. Martin Cannabinoid pharmacological properties common to other centrally acting drugs Eur. J. Pharmacol. 471 2003 185 193 (Pubitemid 36776413)
50. J.L. Wiley, J.W. Huffman, R.L. Balster, and B.R. Martin Pharmacological specificity of the discriminative stimulus effects of delta 9- tetrahydrocannabinol in rhesus monkeys Drug Alcohol Depend. 40 1995 81 86
51. J.L. Wiley, J.A. Marusich, B.R. Martin, and J.W. Huffman 1-Pentyl-3-phenylacetylindoles and JWH-018 share in vivo cannabinoid profiles in mice Drug Alcohol Depend. 123 2012 148 153
52. J.L. Wiley, V.J. Smith, J. Chen, B.R. Martin, and J.W. Huffman Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituents Bioorg. Med. Chem. 20 2012 2067 2081
53. J.L. Wiley, D.E. Selley, P. Wang, R. Kottani, S. Gadthula, and A. Mahadeven 3-Substituted pyrazole analogs of the cannabinoid type 1 (CB1) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB1, non-CB2 mechanism J. Pharmacol. Exp. Ther. 340 2012 433 444
54. J.L. Wiley, D.R. Compton, D. Dai, J.A. Lainton, M. Phillips, J.W. Huffman, and B.R. Martin Structure-activity relationships of indole- and pyrrole-derived cannabinoids J. Pharmacol. Exp. Ther. 285 1998 995 1004 (Pubitemid 28277896)
55. A.R. Winstock, and M.J. Barratt Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample Drug Alcohol Depend. 2013 10.1016/j.drugalcdep.2012.12.011 (Epub ahead of print)
56. A. Wintermeyer, I. Moller, M. Thevis, M. Jubner, J. Beike, M.A. Rothschild, and K. Bender In vitro phase I metabolism of the synthetic cannabimimetic JWH-018 Anal. Bioanal. Chem. 398 2010 2141 2153
57. E.G. Yanes, and D.P. Lovett High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS J. Chromatogr. B 909 2012 42 50
58. J. Zhang, H. Wu, E. Kim, and T.A. El-Shourbagy Salting-out assisted liquid/liquid extraction with acetonitrile: a new high throughput sample preparation technique for good laboratory practice bioanalysis using liquid chromatograph-mass spectrometry Biomed. Chromatogr. 23 2009 419 425
59. Y. Zhang, A. Gilliam, R. Maitra, M.I. Damaj, J.M. Tajuba, H.H. Seltzman, and B.F. Thomas Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor J. Med. Chem. 53 2010 7048 7060